Alpha Teknova Q3 revenue beats estimates on customer segment growth, lifts 2026 outlook
Overview
US reagents producer's Q3 revenue rose 22% yr/yr, beating analyst expectations
Company raised 2026 revenue guidance to $46-48 mln
Completed $46 mln public equity offering in October to strengthen balance sheet
Outlook
Alpha Teknova raises 2026 revenue guidance to $46-48 mln
Company maintains 2026 Free Cash Outflow guidance of less than $8 mln
Result Drivers
CUSTOMER SEGMENT GROWTH - Co said revenue growth was driven by increased sales to life science tools and diagnostics, and biopharma customers, with higher purchases of custom products by small and mid-sized biotech firms and their contract manufacturers
CLINICAL SOLUTIONS SURGE - Clinical Solutions revenue rose 86% yr/yr, outpacing Lab Essentials growth
GROSS MARGIN IMPROVEMENT - Gross margin increased to 38.0% from 30.7%, mainly due to higher revenue and lower fixed cost absorption, partially offset by higher variable costs
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Beat | $12.70 mln | $11.64 mln (7 Analysts) |
Q3 Loss Per Share | $0.06 | ||
Q3 Net Loss | $3.49 mln | ||
Q3 Gross Profit | $4.83 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Alpha Teknova, Inc. is $9.50, about 29.4% above its November 3 closing price of $7.34
Reuters Recommended Reads
Nov 3 - Stevanato Group Q3 revenue beats estimates on biopharma segment
Nov 2 - IDEXX Laboratories Q3 revenue beats estimates, lifts FY profit outlook
Nov 3 - Biomérieux third-quarter organic sales growth beats expectations
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)